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Aspirin and azo derivatives have been widely studied and have drawn considerable attention due to diverse biological activities.
In this study, a series of 4-[(halophenyl)diazenyl]phenyl aspirinate derivatives were synthesized from the reaction of aspirin
with 4-[(halophenyl)diazenyl]phenol via esterification, in the presence of DCC/DMAP in DCM with overall yield of 45–54%. 4-
[(Halophenyl)diazenyl]phenol was prepared prior to esterification from coupling reaction of aniline derivatives and phenol in basic
solution. All compounds were characterized using elemental analysis, FTIR, and 1H and 13C NMR spectroscopies. All compounds
were screened for their anticancer activities against nasopharyngeal cancer (NPC) HK-1 cell lines and the viability of cultured
cells was determined by MTS [3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxylmethoxylphenyl)-2-(4-sulfophenyl)-2H-tetrazolium]-
based colorimetric assay. 4-[(E)-(Fluorophenyl)diazenyl]phenol showed the highest anticancer activity against NPCHK-1 cell lines
compared to other synthesized compounds. 4-[(Halophenyl)diazenyl]phenyl aspirinate showed low cytotoxicity against NPCHK-1
cell lines compared to 4-[(halophenyl)diazenyl]phenol but better anticancer activity than aspirin alone.
1. Introduction
Cancer has become a serious clinical problem worldwide [1].
It is because cancer cells have the ability to grow rapidly and
develop into malignancy tumor [2]. Nasopharyngeal cancer
is the most common malignant tumor and occurs in the
nasopharynx, the upper part of the throat near to the neck [3].
Nasopharyngeal cancer (NPC) is commonly developed from
infection with Epstein-Barr virus, foods, and family history
[4]. NPC, which also known as HK-1, was found to have high
level of epidermal growth factor receptor (EGFR) protein [5].
Hence, by targeting the EGFR protein, it might become a new
therapeutic strategy to inhibit the HK-1 cells [6].The usage of
drugs could stop the growth of the malignant cells in one’s
body by inhibiting its EGFR pathway of the cancer cells itself
[7].
The development of new drug for cancer treatment has
gained much interest in recent years. The modification of
pharmacologically active compounds may lead to a new
finding of novel drugs with diverse pharmacological activities
[8]. Chemical modification of aspirin, for instance, has been
reported to reduce gastrointestinal toxicity and exhibited
diverse biological activities such as anticancer [9], anti-
inflammatory [10], and antibacterial [11, 12] activities. Aspirin
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